Whole Exome Analysis of NIAAA Clinical Center pATIENTS
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Place of performance: Bethesda, MD
Free. Verify your email, then we send one reminder only.
- Posted
- Jun 23, 2026
- Closes
- Rolling, no fixed deadline
Similar opportunities open now
- Multiomic profiling of cardiometabolic diseases (Illumina)Same funderOpenHEALTH AND HUMAN SERVICES, DEPARTMENT OFNo deadline listed
- NIH Brain Development Cohorts BiobankSame funderOpenHEALTH AND HUMAN SERVICES, DEPARTMENT OFNo deadline listed
- REAGENTS TEST KITSOpenDEPT OF DEFENSENo deadline listed
- AJ11--Metabolomics Analysis (Non-GCP)OpenVETERANS AFFAIRS, DEPARTMENT OFNo deadline listed
- 6550--Sources Sought: EPI MULTITOME REAGENTSOpenVETERANS AFFAIRS, DEPARTMENT OFNo deadline listed
At a glance
This is a government contract opportunity posted by HEALTH AND HUMAN SERVICES, DEPARTMENT OF in the biological product (except diagnostic) manufacturing category. Applications are accepted on a rolling basis. Work is performed in Bethesda, MD.
Classification and identifiers
- Industry (NAICS)
- Biological Product (except Diagnostic) Manufacturing (325414)
- Product or service (PSC)
- Drugs and Biologicals (6505)
- Solicitation number
- 75N98026Q00677
- Contracting office
- NATIONAL INSTITUTES OF HEALTH OLAO
Who can apply
No Set aside used. NONE
About this opportunity
The NIAAA Clinical Center patient cohort has been analyzed patients for sequence variant differences, and changes in response to treatment over the course of many years as part of an effort to identify underlying causes of alcohol related disorders. Analysis has previously been performed on over 2000 patients using the AmpliSeq Exome enrichment system and sequenced on the ION sequencing platform because it provides the capability of cost-effective high throughput whole-exome genome-wide analysis. The use of a single enrichment and sequencing platform with consistent information content is essential for analysis of samples screened at different times and it is therefore imperative for analytical integrity that all samples in the study are processed on the same sequencing platform, as each p...